Wednesday, July 8, 2026

pharma · Epilepsy · Attention-Deficit/Hyperactivity Disorder (ADHD) · SUPN

SUPERNUS PHARMACEUTICALS

News and analysis for SUPERNUS PHARMACEUTICALS on NovaPharmaNews — regulatory, clinical, and market coverage.

9715 Key West Ave, Rockville, Maryland 20850, US HQ
2005 Founded
828 Employees
Public company Type
SUPN · NYSE Ticker
Company details
Status
Public
HQ
9715 Key West Ave, Rockville, Maryland 20850, US
Founded
2005
Employees
828
Programs
55
Drugs
25
Patents
68
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning SUPERNUS PHARMACEUTICALS — regulatory, clinical, and market coverage.

News and analysis for SUPERNUS PHARMACEUTICALS on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning SUPERNUS PHARMACEUTICALS yet.

Back to company overview →